EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Potential role of breast MRI to identify patients with high-risk lesions who might avoid surgery: a systematic review and meta-analysis

Giulia Vatteroni, Nina Pirringer-Pötsch, Paola Clauser, Pascal A T Baltzer

European Radiology · 2026

DOI: 10.1007/s00330-025-12291-9 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Radiology, 2026. Verfasst von Giulia Vatteroni und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Milan, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Magnetic Resonance Imaging. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This systematic review and meta-analysis investigate the added value of contrast-enhanced breast MRI (CE-MRI) to rule out malignancy in patients with high-risk (B3) lesions diagnosed at image-guided biopsy. Materials and methods A systematic review and meta-analysis were performed using predefined criteria. Eligible English-language articles published until August 2024 focused on CE-MRI in high-risk lesions. Two reviewers extracted data on true positives (TP), false positives (FP), true negatives (TN), and false negatives (FN). Sensitivity, specificity, negative and positive likelihood ratios were calculated using a bivariate random-effects model. Fagan nomograms identified the maximum pretest probability at which post-test probabilities of a negative MRI matched the 2% malignancy threshold used for downgrading BI-RADS 4 to 3. I² statistics and meta-regression explored heterogeneity. p -values < 0.05 were considered significant.

Results

Seven studies comprising 479 patients with 493 high-risk lesions undergoing CE-MRI were included. The average breast cancer prevalence was 17% (88/493). Pooled sensitivity was 91.3% (95% CI: 82.8–95.8%) and pooled specificity was 68.8% (95% CI: 50.3–82.8%). Only 6/493 malignancies were missed by CE-MRI; all were small low-grade ductal carcinoma in situ (DCIS). Fagan nomograms indicated that CE-MRI could rule out malignancy in lesions with pretest probabilities up to 13.1%.

Conclusions

CE-MRI in assessing high-risk lesions may help identify patients who can safely avoid surgery, potentially reducing morbidity, anxiety, and healthcare resource use. Malignancy can be reliably ruled out in lesions with pretest probabilities ≤ 13.1%, although prospective studies are suggested for confirmation. Key Points Question Can contrast-enhanced breast MRI help to rule out malignancy in patients with high-risk lesions at imaging-guided biopsy, thereby supporting more tailored decisions and potentially reducing unnecessary surgical excisions?

Findings

Contrast-enhanced breast MRI may reduce unnecessary surgical or vacuum excisions in high-risk (B3) lesions. Missed cancers were limited to small low-grade DCIS. Clinical relevance Contrast-enhanced breast MRI may support the identification of patients with high-risk lesions who could potentially avoid surgery. This non-invasive approach has the potential to reduce overtreatment, healthcare costs, and patient anxiety, while maintaining a high negative predictive value. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMagnetic Resonance ImagingHumansFemaleContrast MediaSensitivity and SpecificityImage-Guided BiopsyBreastClinical Relevance

Stichwörter der Autor:innen

B3 lesionsBreast cancerLesions of uncertain malignant potentialMagnetic resonance imagingPatient management

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • Department of Biomedical Imaging and Image-guided Treatment, High field Magnetic Resonance Center (HFMRC), Medical University of Vienna, Vienna, Austria.
  • Department of Biomedical Imaging and Image-guided Treatment, High field Magnetic Resonance Center (HFMRC), Medical University of Vienna, Vienna, Austria. pascal.baltzer@meduniwien.ac.at.

Zitieren

APA

Vatteroni, G., Pirringer-Pötsch, N., Clauser, P., & Baltzer, P. A. T. (2026). Potential role of breast MRI to identify patients with high-risk lesions who might avoid surgery: a systematic review and meta-analysis. European Radiology. https://doi.org/10.1007/s00330-025-12291-9

Vancouver

Vatteroni G, Pirringer-Pötsch N, Clauser P, Baltzer PAT. Potential role of breast MRI to identify patients with high-risk lesions who might avoid surgery: a systematic review and meta-analysis. European Radiology. 2026. doi:10.1007/s00330-025-12291-9

BibTeX
@article{Vatteroni2026,
  author = {Vatteroni, Giulia and Pirringer-Pötsch, Nina and Clauser, Paola and Baltzer, Pascal A T},
  title = {Potential role of breast MRI to identify patients with high-risk lesions who might avoid surgery: a systematic review and meta-analysis},
  journal = {European Radiology},
  year = {2026},
  doi = {10.1007/s00330-025-12291-9}
}
Kostenlos starten →